Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „defined“
Suchtreffer
Begriffe & Kennungen
Peyona (previously Nymusa) · 4.8 · 6 Frequency is defined as: very common (1/10), common (1/100 to 1/10), uncommon (1/1,000 to 1/100), rare
Eintrag öffnenPhesgo · 4.8 · An administration-related reaction was defined in the pivotal trials as any event reported as hypersensitivity
Eintrag öffnenPhesgo · 4.8 · In the pivotal trial FEDERICA, an injection/infusion-related reaction was defined as any systemic reaction rep
Eintrag öffnenPhesgo · 4.8 · Injection site reactions defined as any local reaction reported within 24 hours of Phesgo administration, were
Eintrag öffnenPoherdy · 4.8 · Infusion-related reactions (IRRs) An infusion-related reaction was defined in the pivotal trials as any event
Eintrag öffnenPomalidomide Teva · 4.8 · Frequencies are defined in accordance with current guidance, as: very common (≥1/10), common (≥1/100 to <1/10)
Eintrag öffnenPomalidomide Zentiva · 4.8 · Frequencies are defined in accordance with current guidance, as: very common (≥1/10), common (≥1/100 to <1/10)
Eintrag öffnenPrevymis · 4.8 · 50 defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare
Eintrag öffnenPrevymis · 4.8 · 84 defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare
Eintrag öffnenPrezista · 4.8 · 107 categories are defined as follows: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 t
Eintrag öffnenProcysbi · 4.8 · The frequency of adverse reactions is defined using the following convention: very common (≥1/10); common (≥1/
Eintrag öffnenPrometax · 4.8 · 23 with Prometax in patients with dementia associated with Parkinson’s disease with pre-defined adverse events
Eintrag öffnenPrometax · 4.8 · Pre-defined adverse events that may reflect worsening Prometax Placebo of parkinsonian symptoms in patients wi
Eintrag öffnenPrometax · 4.8 · Pre-defined adverse events that may reflect worsening Prometax Placebo of parkinsonian symptoms in patients wi
Eintrag öffnenPylclari · 4.8 · The frequencies of adverse reactions are defined as follows: Very common (≥1/10), common (≥1/100 to <1/10), Un
Eintrag öffnenQuviviq · 4.8 · The frequency of adverse reactions is defined using the following convention: very common (≥ 1/10); common (≥
Eintrag öffnenRavicti · 4.8 · The adverse reactions are listed below, by system organ class and by frequency. Frequency is defined as very c
Eintrag öffnenRemicade · 4.8 · Infusion-related reactions An infusion-related reaction was defined in clinical studies as any adverse event o
Eintrag öffnenRemsima · 4.8 · An infusion-related reaction was defined in clinical studies as any adverse event occurring during an infusion
Eintrag öffnenRemsima · 4.8 · An infusion-related reaction was defined in clinical studies as any adverse event occurring during an infusion
Eintrag öffnen